Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients.
This study, a retrospective chart review of 82 consecutive male inpatients, assessed the spectrum and prevalence of neuroleptic malignant syndrome. The prevalence of diagnosed neuroleptic malignant syndrome (2.4%) was greater than that generally reported. Eight additional patients manifested symptoms that abated without cessation of neuroleptic treatment. This suggests that neuroleptic malignant syndrome is a spectrum disorder that has milder variants. Affective illness may be a risk factor for its development.
D000293:Adolescent; D000328:Adult; D006753:Hospital Records; D006760:Hospitalization; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D008297:Male; D019964:Mood Disorders / Q000188:drug therapy; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000209:etiology; D012189:Retrospective Studies
D008094:Lithium